On the 12th of February, Orbimed Advisors bought 524 thousand Adicet Bio, Inc. (ACET) shares for $6.8 million at an average price of $13.00 per share. Shares of Adicet Bio, Inc. are down -33.12% since the transaction.
Orbimed Advisors's holding in Adicet Bio, Inc. increased to about 397 thousand shares with the purchase.
Orbimed Advisors first bought Adicet Bio, Inc. stock in the third quarter of 2020.
Other investors who also added to their Adicet Bio, Inc. shares include Citigroup (NYSE:C).